Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Raffaele Cerutti
Observed names:
CERUTTI, RAFFAELE,
Cerutti, Raffaele,
R. Cerutti
Institutions:
University of Padua,
Veneto Institute of Molecular Medicine
Observed institutions:
University of Padua,
University of Milan,
University of Cambridge,
Veneto Institute of Molecular Medicine,
Fondazione IRCCS Istituto Neurologico Carlo Besta,
MRC Mitochondrial Biology Unit,
Wellcome Trust
show all 7
ORCID:
0009-0000-6939-8684
Observed ORCID:
0009-0000-6939-8684
OpenAlex ID:
A5061928867
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
2014
·
Raffaele Cerutti
, Eija Pirinen
, et al.
·
Cell Metabolism
·
342
PDF
Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo
2018
·
Payam A. Gammage
, Carlo Viscomi
, et al.
·
Nature Medicine
·
304
PDF
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
2011
·
Carlo Viscomi
, Emanuela Bottani
, et al.
·
Cell Metabolism
·
292
PDF
Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
2015
·
Gabriele Civiletto
, Tatiana Varanita
, et al.
·
Cell Metabolism
·
215
PDF
Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis
2018
·
Gabriele Civiletto
, Sukru Anil Dogan
, et al.
·
EMBO Molecular Medicine
·
116
PDF
Perturbed Redox Signaling Exacerbates a Mitochondrial Myopathy
2018
·
Sukru Anil Dogan
, Raffaele Cerutti
, et al.
·
Cell Metabolism
·
98
PDF
TTC19 Plays a Husbandry Role on UQCRFS1 Turnover in the Biogenesis of Mitochondrial Respiratory Complex III
2017
·
Emanuela Bottani
, Raffaele Cerutti
, et al.
·
Molecular Cell
·
82
PDF
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration
2015
·
Dario Brunetti
, Janniche Torsvik
, et al.
·
EMBO Molecular Medicine
·
77
PDF
A Single Intravenous Injection of AAV-PHP.B-hNDUFS4 Ameliorates the Phenotype of Ndufs4 Mice
2020
·
Pedro Silva-Pinheiro
, Raffaele Cerutti
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
46
PDF
The ferredoxin‐NADP+ reductase/ferredoxin electron transfer system of Plasmodium falciparum
2009
·
Emanuela Balconi
, Andrea Pennati
, et al.
·
FEBS Journal
·
44
PDF
APOPT1/COA8 assists COX assembly and is oppositely regulated by UPS and ROS
2018
·
Alba Signes
, Raffaele Cerutti
, et al.
·
EMBO Molecular Medicine
·
38
PDF
SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype
2018
·
C. Quadalti
, D. Brunetti
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
35
PDF
DNA polymerase gamma mutations that impair holoenzyme stability cause catalytic subunit depletion
2021
·
Pedro Silva-Pinheiro
, Carlos Pardo-Hernández
, et al.
·
Nucleic Acids Research
·
31
PDF
Opa1 Overexpression Protects from Early-Onset Mpv17−/−-Related Mouse Kidney Disease
2020
·
Marta Luna-Sanchez
, Cristiane Benincá
, et al.
·
Molecular Therapy
·
15
PDF
Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4−/− mice
2022
·
Samantha Corrà
, Raffaele Cerutti
, et al.
·
Brain
·
14
PDF
Modelling POLG mutations in mice unravels a critical role of POLγΒ in regulating phenotypic severity
2025
·
Samantha Corrà
, Alessandro Zuppardo
, et al.
·
Nature Communications
·
8
PDF
Correction to ‘DNA polymerase gamma mutations that impair holoenzyme stability cause catalytic subunit depletion’
2021
·
Pedro Silva-Pinheiro
, Carlos Pardo-Hernández
, et al.
·
Nucleic Acids Research
·
3
PDF
Opantimirs: A class of antagonizing microRNAs that upregulate Opa1 and improve mitochondrial and disuse myopathies
2025
·
Andre Djalalvandi
, Keisuke Takeda
, et al.
·
Cell Reports Medicine
·
1
Mitochondrial Disease: From Mechanisms to Therapy
2024
·
Valeria Balmaceda
, Raffaele Cerutti
, et al.
·
RedoXplore.
PDF
AAV-based therapy for mitochondrial diseases and optic neuropathies
2024
·
Carlo Viscomi
, Valeria Balmaceda
, et al.
·
Biochimica et Biophysica Acta (BBA) - Bioenergetics
Correction to 'DNA polymerase gamma mutations that impair holoenzyme stability cause catalytic subunit depletion'.
2021
·
Silva-Pinheiro, Pedro
, Pardo-Hernández, Carlos
, et al.
·
Apollo (University of Cambridge)
DNA polymerase gamma mutations that impair holoenzyme stability cause catalytic subunit depletion.
2021
·
Silva-Pinheiro, Pedro
, Pardo-Hernández, Carlos
, et al.
·
Apollo (University of Cambridge)
In vivo and in vitro mechanistic characterization of a clinically relevant PolγA mutation
2020
·
Pedro Silva-Pinheiro
, Carlos Pardo-Hernández
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
MITOCHONDRIAL DISEASES I (Oral)
2018
·
M. Zeviani
, A. Dogan
, et al.
·
Neuromuscular Disorders
Mitochondrial diseases: from mechanisms to therapies
2018
·
Carlo Viscomi
, Anil Dogan
, et al.
·
Biochimica et Biophysica Acta (BBA) - Bioenergetics
PDF
Show more works
View as search
Works count:
31
Citation count:
1,762
H-index:
14
I10-index:
15
Year
Topic
Type
